BOPA-PRUK Research Award – NOW OPEN for Applications 2021

The BOPA-PRUK research award

This award provides pharmacy professionals who are new to research with the extra incentive to get their research career started.

Pharmacy Research UK (PRUK) and the British Oncology Pharmacy Association (BOPA) have collaborated together for 5 years to provide this opportunity to oncology and haematology pharmacy colleagues.  Multiple people have already benefited from this generous award.

This year, the award is worth £20,000. This allows us to offer the whole amount to a single person or to break the award down to offer more people smaller amounts of a minimum of £5,000. The funding can be used to partly or fully fund a research project.

Any member of the pharmacy team can apply. Projects must be related to the provision of oncology or haematology pharmacy services directly impacting patient care and benefit.

For further information please refer to the PRUK website. We recommend you read through all the material contained within the PRUK website before starting your application.

PRUK offer a mentoring scheme available to pharmacy professionals who wish to seek guidance and support for developing their research skills. If you think you could benefit from this please refer to the PRUK webpage.

Visit back soon to hear from some of our previous winners to give you tips and ideas for your research project.

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article